Physician profile
Starla Johnson
NPI 1871872069
$981.46
in general payments reported to CMS, 2019-2025
15 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $166 · 2023: $153 · 2024: $358 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $195.93 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $180.93 | 2022-2025 | |
| Dexcom, INC. | $110.08 | 2022-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $82.32 | 2022-2024 | Gardasil 9, Gardasil, M-M-R II |
| Abbvie INC. | $71.54 | 2022-2023 | |
| Glaxosmithkline, LLC. | $69.79 | 2021-2023 | Trelegy Ellipta |
| Cipher Pharmaceuticals US LLC | $50.55 | 2025 | Spinosad, Natroba |
| Astrazeneca Pharmaceuticals LP | $40.22 | 2024-2025 | Breztri |
| Exact Sciences Corporation | $35.23 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbott Laboratories | $34.42 | 2021-2024 | Proclaim |
| Novo Nordisk INC | $33.55 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $16.71 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.47 | 2022 | |
| Organon LLC | $13.77 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Starla Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.